A venom component from the Taipan, the world’s deadliest snake, is being developed by Brisbane biotechnology company ElaCor, as a new drug to treat heart failure.
21 February 2005A venom compound from the world’s deadliest snake, the Taipan, is being developed by Brisbane biotechnology company ElaCor, as a new drug to treat heart failure.
29 November 2004The world`s leading experts on developing drugs from the venom of poisonous creatures, will descend on Heron Island on Queensland’s Great Barrier Reef from July 14-19.
12 June 2002The University of Queensland has attracted the largest Australian Research Council (ARC) Discovery grant for a project investigating potential new drug therapies derived from the venom of marine snails.
24 September 2001For the first time in Australia, a University of Queensland molecular biologist has analysed at a molecular level the toxins of funnel-web venom from a spider responsible for the near death of its victim.
18 June 2001Young University of Queensland scientist Dr Peter Cassidy has invested six years of his life in building frameworks for new drugs.
25 October 2000Xenome Ltd Company targets new generation pharmaceuticals from the venom of Australia's unique fauna
Xenome Ltd Company targets new generation pharmaceuticals from the venom of Australia's unique fauna Queensland's rapidly emerging biotechnology industry will be enhanced with the establishment of Xenome Limited, an IMB spin-off company...
9 March 2000The poison chalice of a humble marine snail is fast becoming the Holy Grail of pain relieving drugs.
6 October 1999Queensland Governor Major General Peter Arnison today will visit research laboratories associated with the University of Queensland's planned $100m Institute for Molecular Bioscience at St Lucia at 3pm.
3 August 1999University of Queensland researchers have attracted the top two Australian Research Council (ARC) equipment grants to Queensland for 1999.
15 March 1999The University of Queensland's Centre for Drug Design and Development has launched three spin-off biotechnology companies to further develop intellectual property and commercialise the results of its research.
26 February 1999The University of Queensland's Centre for Drug Design and Development (3D) has experienced one of its most successful years in funding grants
24 February 1999The University of Queensland's Centre for Drug Design and Development (3D Centre) and CSIRO are jointly supporting a $350,000 refurbishment of levels seven and eight of the Gehrmann Laboratories at St Lucia.
24 February 1999The University of Queensland has maintained its position as one of the nation's leading research universities by attracting the second-highest number of new large project grants in 1999 allocations from the Australian Research Council (ARC)
3 December 1998University of Queensland researchers have found that a hormone they discovered years ago has the potential to treat some cancers, accelerate wound healing, prevent rejection of transplanted organs and control auto-immune disease.
20 March 1998University of Queensland researchers have found that a hormone they discovered years ago has the potential to treat some cancers, accelerate wound healing, prevent rejection of transplanted organs and control auto-immune disease.
17 March 1998
